Myriad Genetics (MYGN) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 56.76% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 33.71% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -9.74% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 15.11% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 15.10% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 25.51% |
| 10 | Myriad Genetics | 300.99 Mn | 185.79 Mn | 127.00 Mn | 86.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86.93% |
| Mar 31, 2026 | -34,000.00% |
| Dec 31, 2025 | 81.41% |
| Sep 30, 2025 | -23.98% |
| Jun 30, 2025 | -800.54% |
| Mar 31, 2025 | 99.62% |
| Dec 31, 2024 | -36.22% |
| Sep 30, 2024 | 63.95% |
| Jun 30, 2024 | 68.39% |
| Mar 31, 2024 | 52.47% |
| Dec 31, 2023 | 26.24% |
| Sep 30, 2023 | -74.64% |
| Jun 30, 2023 | -723.40% |
| Mar 31, 2023 | -166.83% |
| Dec 31, 2022 | -456.58% |
| Sep 30, 2022 | -242.68% |
| Jun 30, 2022 | -200.00% |
| Mar 31, 2022 | 48.10% |
| Dec 31, 2021 | 85.69% |
| Sep 30, 2021 | 113.23% |